An advanced decellularized dermis intended for soft tissue repair: A new surgical approach for DFU
1 Foot Secure, Foot and Anckle Clinics, Bengaluru, India.
2 Department of Biotechnology, University of Padua, Italy.
Case Study
Magna Scientia Advanced Biology and Pharmacy, 2022, 06(01), 012–015
Article DOI: 10.30574/msabp.2022.6.1.0064
Publication history:
Received on 02 April 2022; revised on 06 May 2022; accepted on 08 May 2022
Abstract:
Skin substitutes are heterogeneous group of biological and/or synthetic elements that enable the temporary or permanent occlusion of wounds. Although dermal substitutes can vary from skin xenografts or allografts to a combination of autologous keratinocytes over the dermal matrix, their common objective is to achieve the greatest possible similarity with the patient’s skin The acellular dermal matrix allows the body to rebuild its own strong tissue without the need for alloplastic material. The three-dimensional collagen will be replaced by vital new tissue. An alternative treatment for diabetic foot ulcers is a matrix scaffold for new tissue generation, an acellular human dermal matrix (ADM) allograft. Decellularized human skin has been used for a variety of medical procedures, primarily involving wound healing, soft tissue reconstruction, and sports medicine applications.
Keywords:
Wound Healing; Diabetes; Chronic Wounds; Skin Substitutes; Skin Dressings; Matrices; ADM
Full text article in PDF:
Copyright information:
Copyright © 2022 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0